BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12494915)

  • 1. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
    Nakazawa Y; Joseph K; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1851-9. PubMed ID: 12489799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
    Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
    Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
    Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the plasma kinin forming cascade along cell surfaces.
    Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
    Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
    Joseph K; Ghebrehiwet B; Kaplan AP
    Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
    Mahdi F; Shariat-Madar Z; Schmaier AH
    J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells.
    Mahdi F; Shariat-Madar Z; Todd RF; Figueroa CD; Schmaier AH
    Blood; 2001 Apr; 97(8):2342-50. PubMed ID: 11290596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the cell binding site on high molecular weight kininogen domain 5.
    Hasan AA; Cines DB; Herwald H; Schmaier AH; Müller-Esterl W
    J Biol Chem; 1995 Aug; 270(33):19256-61. PubMed ID: 7642598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of activation of kinin-forming proteins on vascular endothelial cells.
    Kaplan AP; Joseph K; Shibayama Y
    Immunopharmacology; 1997 Jun; 36(2-3):201-7. PubMed ID: 9228547
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.
    Mahdi F; Madar ZS; Figueroa CD; Schmaier AH
    Blood; 2002 May; 99(10):3585-96. PubMed ID: 11986212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of bradykinin: a major contributor to the innate inflammatory response.
    Joseph K; Kaplan AP
    Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):896-900. PubMed ID: 11792853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.